 Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals VRTXResearch Report and Apellis Pharmaceuticals APLSResearch Report.Vertex Pharmaceuticals VRTXCredit Suisse analystEvan Seige 